Home

Pre-symptomatic targeted treatment of patent ductus arteriosus in preterm newborns: A systematic review and meta-analysis

April 29th 2019 | Farooqui, M.A.*, Elsayed, Y.N., Jeyaraman, M.M., Dingwall, O., Tagin, M., Zarychanski, R., Rabbani, R., Abou-Setta, A.M.

Abstract.
BACKGROUND: A clinically significant patent ductus arteriosus (PDA) is associated with significant morbidity and mortality in premature newborns. Symptomatic PDAs are often treated with prostaglandin synthesis inhibitors (PSI), but controversy remains if PSIs should also be...

Reviews

Pre-symptomatic targeted treatment of patent ductus arteriosus in preterm newborns: A systematic review and meta-analysis

Research

Enteral feeding in duct-dependent congenital heart disease

Enteral fish oil supplementation in the resolution of parenteral nutrition associated cholestasis

Clinical Cases

Natural drugs, not so natural effects: Neonatal abstinence syndrome secondary to ‘kratom’

Subscribe to Front page feed